Sylvie Chevret

60.1k citations

598 papers · 28.1k indexed · 5 hit papers · h-index 87

Impact in

Critical Care and Intensive Care Medicine top 0.05%
- Nosocomial Infections in ICU
Hematology top 0.05%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation

Papers in

Hematology 131
- Acute Myeloid Leukemia Research 60
- Hematopoietic Stem Cell Transplantation 40
- Multiple Myeloma Research and Treatments 32
Statistics and Probability 64
- Statistical Methods in Clinical Trials 48

Co-authors: Benoı̂t Schlemmer Claude Chastang Élie Azoulay Philippe Gajdos Djillali Annane Frédéric Pochard Matthieu Resche‐Rigon Pierre Fenaux
Journals: Blood (75 papers)Journal of Clinical Oncology (18 papers)Critical Care Medicine (18 papers)Statistics in Medicine (18 papers)Intensive Care Medicine (17 papers)
Partner nations: France United States United Kingdom

In The Last Decade

Sylvie Chevret

573 papers receiving 27.2k citations

Hit Papers

5 papers align trajectories log scale

Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials 2014 · 479 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 The Lancet Oncology
2006 American Journal of Respiratory and Critical Care Medicine
2003 JAMA
2001 Critical Care Medicine
2000 Critical Care Medicine

Peers

Countries citing papers authored by Sylvie Chevret

Since Specialization

Citations

This map shows the geographic impact of Sylvie Chevret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Chevret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Chevret more than expected).

Fields of papers citing papers by Sylvie Chevret

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Chevret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Chevret. The network helps show where Sylvie Chevret may publish in the future.

Co-authors

The 25 scholars most cited alongside Sylvie Chevret, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sylvie Chevret Line = papers co-authored together Sylvie Chevret links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	French evaluation of innovative health technologies: Early access and fundings La Presse Médicale ·Nicola Margerie, Sylvie Chevret, Yi Qing Chen, Gong Wei, Françoise Hidden‐Lucet, VLAD-ALEXANDRU PORUMB, P Breton, Naveen Ph.D, Pierre Cochat	2025	2
2	Combining ESA and Luspatercept in Non-RS MDS Patients Having Failed ESA - Results of the Phase 1-2 Part a of the GFM Combola Study Blood ·Lionel Adès, Thomas Cluzeau, Thibault Comont, K Nakajima, Aspasia Stamatoullas, Brigitte Scriba, Emmanuel Gyan, Alice Garnier, Maud D’Aveni, Sylvain Thépot, Marie Sébert, J.C. Kohlmeyer, Anouk Walter‐Petrich, J. P. Adler, Fatiha Chermat, Michaëla Fontenay, Sylvie Chevret, Padmaja Veeramreddy	2024	3
3	Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström’s macroglobulinemia Annals of Hematology ·Cécile Tomowiak, Stéphanie Poulain, 沈国征, Pierre Feugier, Charles Herbaux, Beatrice Mahé, Pierre Morel, Thérèse Aurran, Olivier Tournilhac, Stéphane Leprêtre, Souad Assaad, Bruno Villemagne, Olivier Casasnovas, Jane Joyce, Damien Roos‐Weil, José Miguel Torregrosa Diaz, Sylvie Chevret, Véronique Leblond, (unknown)	2024	2
4	Vaginal misoprostol versus vaginal dinoprostone for cervical ripening and induction of labour: An individual participant data meta‐analysis of randomised controlled trials BJOG An International Journal of Obstetrics & Gynaecology ·Malitha Patabendige, 贾孝敏, Christophe Vayssière, Virginie Ehlinger, Zhengfa Wen, Saskia le Cessie, Бычков Александр Владимирович, Lena Marions, Patrick Rozenberg, Sylvie Chevret, David C. Young, Shakeer Mohammed, Isabelle de Lamberterie, Mark Waterstone, Daniel L. Rolnik, Ben W. Mol, Wentao Li	2024	7
5	Factors Associated With Treatment Pathways in Early Axial Spondyloarthritis: A Multistate Analysis of the 10-Year Follow-Up of the DESIR Cohort The Journal of Rheumatology ·Mekawy Ouda, Sylvie Chevret, Anouk Walter‐Petrich, Adeline Ruyssen‐Witrand, Maxime Dougados, Anna Moltó	2024	1
6	Improvement of an External Predictive Model Based on New Information Using a Synthetic Data Approach Neurology Genetics ·Yougen Zhan, Hugues Chabriat, Jerzy Foit, J. Poehlsen, Bradfield, Sylvie Chevret, Lucie Biard	2023	2
7	Real-World Diagnostic Accuracy of the On-Site Cytopathology Advance Report (OSCAR) Procedure Performed in a Multidisciplinary One-Stop Breast Clinic Cancers ·Voïchita Suciu, Bagus Geriansyah Putra, Charitha Hettiarachchi, Marie‐Christine Mathieu, Corinne Balleyguier, Suzette Delaloge, Zsófia Balogh, Jean‐Yves Scoazec, Sylvie Chevret, Philippe Vielh	2023	4
8	Early complete response as a validated surrogate marker in extranodal marginal zone lymphoma systemic therapy Blood ·Cristiano Vieira Sobrinho, Emanuele Zucca, Sylvie Chevret, Annarita Conconi, Grzegorz S. Nowakowski, Matthew J. Maurer, James R. Cerhan, Catherine Thiéblemont, Jérôme Lambert	2023	2
9	Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) The Lancet Regional Health - Americas ·Alice Tung Wan Song, Vanderson Rocha, Alfredo Mendrone, Rodrigo T. Calado, Gil Cunha De Santis, Bruno Deltreggia Benites, Carolina Costa-Lima, Yichen Lei, Yolima Borja Acuña, JUGuo-Xing, Sasmita Rout, Silvano Wendel, Roberta Fachini, Luiz Vicente Rizzo, José Mauro Kutner, Vivian I. Avelino‐Silva, Rafael Rahal Guaragna Machado, Edison Luíz Durigon, Sylvie Chevret, Esper G. Kallás	2022	8
10	Interstitial lung diseases after hematopoietic stem cell transplantation: New pattern of lung chronic graft-versus-host disease? Bone Marrow Transplantation ·Gabrielle Archer, Ingrid Berger, Louise Bondeelle, Constance de Margerie‐Mellon, Sabrina Renaud, Régis Peffault de Latour, David Michonneau, Sylvie Chevret, Anne Bergeron	2022	9
11	Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma Bone Marrow Transplantation ·J. NAICAMICHI, Roberta Di Blasi, Florence Morin, Eugenio Galli, Vincent Allain, Pashé Douglas-Sampson, Laëtitia Vercellino, Nathalie Parquet, Miryam Mebarki, Jérôme Larghero, É. de Kerviler, Isabelle Madelaine, Sophie Caillat‐Zucman, Sylvie Chevret, Catherine Thiéblemont	2022	43
12	Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocols Leukemia ·Mary Taj, Anthony V. Moorman, Chris Rub, Arnaud Petit, Vahid Asnafi, Fanny Alby‐Laurent, Ajay Vora, Marc R. Mansour, Rosemary E. Gale, Sylvie Chevret, John Moppett, André Baruchel, Elizabeth Macintyre	2021	4
13	Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients Bone Marrow Transplantation ·D BROEKAERT, Louise Bondeelle, Maud Salmona, Jérôme LeGoff, Régis Peffault de Latour, F. Rivière, C. Soler, Véronique Houdouin, Jean‐Hugues Dalle, Edgar Ibarra-Núñez, Slim Fourati, Frank Griscelli, Téreza Coman, Sylvie Chevret, Anne Bergeron	2021	11
14	Lenalidomide Enhance CAR T-Cells Response in Patients with Refractory/Relapsed Large B Cell Lymphoma Experiencing Progression after Infusion Blood ·Catherine Thiéblemont, Sylvie Chevret, Vincent Allain, Roberta Di Blasi, Florence Morin, Laëtitia Vercellino, Sandrine Roulland, Karin Tarte, Véronique Meignin, Sophie Caillat‐Zucman	2020	16
15	G-CSF does not worsen toxicities and efficacy of CAR-T cells in refractory/relapsed B-cell lymphoma Bone Marrow Transplantation ·Eugenio Galli, Vincent Allain, Roberta Di Blasi, Sophie Bernard, Laëtitia Vercellino, Florence Morin, Hannah Moatti, Sophie Caillat‐Zucman, Sylvie Chevret, Catherine Thiéblemont	2020	42
16	Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia Blood ·Arnaud Petit, Amélie Trinquand, Sylvie Chevret, Paola Ballerini, Jean‐Michel Cayuela, Nathalie Grardel, Aurore Touzart, Benoît Brethon, Hélène Lapillonne, Claudine Schmitt, Sandrine Thouvenin, Gérard Michel, Claude Preudhomme, Jean Soulier, Judith Landman‐Parker, Guy Leverger, Elizabeth Macintyre, André Baruchel, Vahid Asnafi	2017	61
17	Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis Cancer Epidemiology Biomarkers & Prevention ·Jean‐Charles Nault, Erwan Guyot, Christelle Laguillier, Sylvie Chevret, Nathalie Ganne‐Carrié, G. Nkontchou, Michel Beaugrand, Olivier Séror, Jean–Claude Trinchet, Sarah R. Crossland, G Maass, Nathalie Charnaux, Maryse Delehedde, Angéla Sutton, Pierre Nahon	2013	65
18	Procedure volume is one determinant of centre effect in mechanically ventilated patients European Respiratory Journal ·Michaël Darmon, Élie Azoulay, R Handawati, B. Garrigues, Michał Domański, Pierre Moine, D. Villers, Magri, Raquel Teixeira Gomes, 1969-, Samantha J. Walters, Sylvie Chevret	2010	10
19	The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases Blood ·Jean‐Jacques Kiladjian, Francisco Cervantes, Frank W.G. Leebeek, Christophe Marzac, Bruno Cassinat, Sylvie Chevret, Dominique Cazals‐Hatem, Aurélie Plessier, Juan Carlos García‐Pagán, Sarwa Darwish Murad, S. Raffa, Harry L.A. Janssen, Claude Gardin, Sophie Cereja, Carole Tonetti, Stéphane Giraudier, Bertrand Condat, Nicole Casadevall, Pierre Fenaux, Dominique Valla	2008	227
20	Systemic Inflammatory Response and Progression to Severe Sepsis in Critically Ill Infected Patients American Journal of Respiratory and Critical Care Medicine ·Corinne Alberti, Christian Brun‐Buisson, Sylvie Chevret, Massimo Antonelli, Sergey Goodman, Claudio M. Martin, Rui P. Moreno, A. Ochagavía, Mark Palazzo, Karl Werdan, Jean Roger Le Gall	2004	134

About Sylvie Chevret

Sylvie Chevret is a scholar working on Hematology, Statistics and Probability, Critical Care and Intensive Care Medicine, Genetics and Epidemiology, having authored 598 papers that have together received 28.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (60 papers), Statistical Methods in Clinical Trials (48 papers), Hematopoietic Stem Cell Transplantation (40 papers), Sepsis Diagnosis and Treatment (38 papers), Chronic Lymphocytic Leukemia Research (35 papers), Multiple Myeloma Research and Treatments (32 papers), Acute Lymphoblastic Leukemia research (32 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (32 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (3.1k citations), Hematology (5.8k citations), Applied Microbiology and Biotechnology (629 citations), Radiological and Ultrasound Technology (1.6k citations) and Genetics (3.3k citations). Sylvie Chevret has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Benoı̂t Schlemmer, Claude Chastang, Élie Azoulay, Philippe Gajdos, Djillali Annane, Frédéric Pochard, Matthieu Resche‐Rigon, Pierre Fenaux, Michel Wolff and Jean‐Roger Le Gall. Their work appears in journals such as Blood, Journal of Clinical Oncology, Critical Care Medicine, Statistics in Medicine and Intensive Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact